Acquisition

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

The global investment bank is buying the boutique firm behind landmark deals for Liverpool FC and the NY Mets to dominate the booming sports finance market.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

With veteran Jason Montrie at the helm, Alerion Advisors aims to build an integrated platform to solve health plans' biggest operational headaches.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

Following a key Gartner recognition, Aegis Software is integrating digital twins and AI to move factories from reactive execution to predictive intelligence.

In a market focused on scale, Silvester & Company's acquisition of ChampionScott Partners signals a strategic shift toward specialized, future-focused leadership.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

As AI fakes threaten truth, Reality Defender recruits pioneers from Google, Twitter, and academia to build an ethical framework for detection technology.

With new COO Sarah Campbell and fresh capital, Future Technologies is scaling aggressively to solve the critical 'AI Connectivity Gap' for major industries.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

Atkore's Q2 revenue rose 4.2%, but a $136.5M antitrust settlement drove a major net loss. The company divests assets to focus on its electrical core.

The ticket marketplace saw revenue fall year-over-year, but a surge in cash flow and sequential growth offers a potential path to recovery.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

As enterprises deploy advanced AI, a new security market is set to explode from zero to $8B by 2030, forcing a rethink of how we protect intelligent systems.

With private equity backing and a new CEO known for transformation, the Portuguese ACMI specialist is doubling its fleet to capture a volatile market.

A new AI tool promises to turn complex financial contracts from a multi-hour headache into minutes of work, reducing risk and unlocking strategic value.

Meren Energy's upcoming Q1 2026 results will be scrutinized for its performance in Africa's deepwater projects amidst soaring oil prices and strategic shifts.